Insider · CIK 1817160

Gwenn Hansen

Chief Scientific Officer at Nurix Therapeutics NRIX

Open-market buys0
Open-market sales3
Bought$0
Sold$195K

Every trade, with what the company filed around it

Open-market buys and sales as each Form 4 states them, newest first.

How these figures work

Notes on each row are as each Form 4 states them, next to SEC Tracker's own records of the company's filings and other insiders' buys. Holding after is what the filing reports they held after the trade, with the change in their holding.

DateCompanyTradeValueHolding afterNotes
Nov 2, 2026Nurix Therapeutics NRIXSold (10b5-1) 1,452 sh at $26.80
The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026.
$39K123,452 −1%
The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026.
Oct 30, 2026Nurix Therapeutics NRIXSold (10b5-1) 3,957 sh at $26.28
The filing says this sale was under a Rule 10b5-1 plan set up in advance. 16 days after a Form 144 notice of a planned insider sale filed Oct 14, 2026.
$104K123,452 −3%
The filing says this sale was under a Rule 10b5-1 plan set up in advance. 16 days after a Form 144 notice of a planned insider sale filed Oct 14, 2026.
Oct 30, 2025Nurix Therapeutics NRIXSold 4,087 sh at $12.80
The filing does not mark this sale as under a Rule 10b5-1 plan. 8 days after the company's 8-K filed Oct 22, 2025.
$52K76,751 −5%
The filing does not mark this sale as under a Rule 10b5-1 plan. 8 days after the company's 8-K filed Oct 22, 2025.

Open-market trades are Form 4 transaction codes P (purchase) and S (sale). Planned sales are those the filing marks as made under a Rule 10b5-1 plan. A P-code buy at the offering price within a day of the company's FWP, 424B prospectus or offering 8-K is marked Bought in the offering and left out of open-market buy counts and cluster buys. Prices and values are as stated in each Form 4. Stock prices aren't shown on this page. Not investment advice.